Recent Finacing
Recent Raise
Altheos is an early-stage South San Francisco biopharmaceutical company developing small-molecule therapeutics, including ATS907, a selective Rho‑kinase inhibitor, and the AK138 topical glaucoma compound series.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors